Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Skylark Bio, Inc.

Skylark Bio, Inc.

Stage unknownCambridge, MAskylarkbio.comBiotechnology
Facts
Year of incorporation
2021sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
1 rounds
  1. Aug 8, 2022
    Form D equity offering · $40.9M (form d sold) · 2 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Skylark Bio, Inc. filed Form D/A: $40,889,315 sold of $40,889,315, Biotechnology”
Investors on record
2 edges
People
2 officers, 2 directors
Timeline
1
  1. Apr 19, 2024
    Skylark Bio, Inc. filed Form D/A: $40,889,315 sold of $40,889,315, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
20 observations
Every observation on this company